Posts With Tag ADS ratio change

Explore TC BioPharm's recent Form 6-K filing detailing the ADS ratio change, trading impacts, and warrant adjustments, essential for investors and stakeholders.

Discover Evaxion Biotech A/S's significant shift in ADS ratio from 1:10 to 1:50, effective January 14, 2025. Understand implications for shareholders and market impact.

Evaxion Biotech A/S updates investors on a new ADS ratio effective January 13, 2025, enhancing liquidity. Key details on exchange process and expected price movement included.